Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
National Cancer Database (NCDB)
oropharyngeal squamous cell carcinoma
oropharynx
transoral robotic surgery (TORS)
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
07
03
2021
received:
10
10
2020
accepted:
14
04
2021
pubmed:
27
4
2021
medline:
2
7
2021
entrez:
26
4
2021
Statut:
ppublish
Résumé
The aim of this study is to evaluate the impact of transoral robotic surgery (TORS) compared to nonrobotic surgery (NRS) on overall survival in oropharyngeal squamous cell carcinoma (OPSCC). We performed a retrospective study of patients with HPV+ and HPV- OPSCC undergoing TORS or NRS with neck dissection using the National Cancer Database from the years 2010-2016. Among patients with OPSCC in our cohort, 3167 (58.1%) patients underwent NRS and 2288 (41.9%) underwent TORS. TORS patients demonstrated better overall survival than NRS patients (HPV+ patients: aHR 0.74, p = 0.02; HPV- patients: aHR 0.58, p < 0.01). Subsite analysis showed TORS was correlated with improved survival in base of tongue (BoT) primaries for both HPV+ (aHR 0.46, p = 0.01) and HPV- (aHR 0.42, p = 0.01) OPSCC. Compared to NRS, TORS is associated with improved overall survival for HPV+ and HPV- OPSCC, as well as greater overall survival for BoT primaries.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2259-2273Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Mahmoud O, Sung K, Civantos FJ, Thomas GR, Samuels MA. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus. Head Neck. 2018;40(4):710-721. https://doi.org/10.1002/hed.25036.
The United States Food and Drug Administration. 501(k) summary, section III: indications for use for Intuitive surgical endoscopic instrument control system. 2009. https://www.accessdata.fda.gov/cdrh_docs/pdf9/K090993.pdf. Accessed December 21, 2020.
O'Malley BW, Weinstein GS, Snyder W, Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006;116(8):1465-1472. https://doi.org/10.1097/01.mlg.0000227184.90514.1a.
Weinstein GS, O'Malley BW, Magnuson JS, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope. 2012;122(8):1701-1707. https://doi.org/10.1002/lary.23294.
Holsinger FC, McWhorter AJ, Ménard M, Garcia D, Laccourreye O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg. 2005;131(7):583-591. https://doi.org/10.1001/archotol.131.7.583.
Laccourreye O, Hans S, Ménard M, Garcia D, Brasnu D, Holsinger FC. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg. 2005;131(7):592-599. https://doi.org/10.1001/archotol.131.7.592.
Haigentz M, Silver CE, Corry J, et al. Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009;266(12):1845-1855. https://doi.org/10.1007/s00405-009-1109-2.
Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. Int J Radiat Oncol Biol Phys. 2013;85(5):1163-1167. https://doi.org/10.1016/j.ijrobp.2012.08.033.
White H, Ford S, Bush B, et al. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Head Neck Surg. 2013;139(8):773-778. https://doi.org/10.1001/jamaoto.2013.3866.
Baskin RM, Boyce BJ, Amdur R, et al. Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations. Cancer Manag Res. 2018;10:839-846. https://doi.org/10.2147/CMAR.S118891.
Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007;117(1):16-21. https://doi.org/10.1097/01.mlg.0000240182.61922.31.
Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589. https://doi.org/10.1200/JCO.2007.14.8841.
Gal TJ, Slezak JA, Kejner AE, Chen Q, Huang B. Treatment trends in oropharyngeal carcinoma: surgical technology meets the epidemic. Oral Oncol. 2019;97:62-68. https://doi.org/10.1016/j.oraloncology.2019.08.007.
Mukhija VK, Sung C-K, Desai SC, Wanna G, Genden EM. Transoral robotic assisted free flap reconstruction. Otolaryngol Head Neck Surg. 2009;140(1):124-125. https://doi.org/10.1016/j.otohns.2008.09.024.
Lee SY, Park YM, Byeon HK, Choi EC, Kim S-H. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck. 2014;36(8):1138-1145. https://doi.org/10.1002/hed.23424.
Ford SE, Brandwein-Gensler M, Carroll WR, Rosenthal EL, Magnuson JS. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status. Otolaryngol Head Neck Surg. 2014;151(4):606-611. https://doi.org/10.1177/0194599814542939.
Zevallos JP, Mitra N, Swisher-McClure S. Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma. Head Neck. 2016;38(3):402-409. https://doi.org/10.1002/hed.23909.
National Cancer Database. American College of Surgeons. https://ncdbpuf.facs.org/. Accessed May 27, 2020.
Amin MB, Edge S, Green F, et al. AJCC Cancer Staging Manual (8th edition). New York, NY: Springer; 2017.
Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. https://doi.org/10.1186/1751-0473-3-17.
Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34(5):299-309.
Dowthwaite SA, Franklin JH, Palma DA, Fung K, Yoo J, Nichols AC. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol. 2012;2012:945162. https://doi.org/10.5402/2012/945162.
Baliga S, Kabarriti R, Jiang J, et al. Utilization of transoral robotic surgery (TORS) in patients with oropharyngeal squamous cell carcinoma and its impact on survival and use of chemotherapy. Oral Oncol. 2018;86:75-80. https://doi.org/10.1016/j.oraloncology.2018.06.009.
de Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096-2102. https://doi.org/10.1002/lary.24712.
Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol. 2007;85(1):64-73. https://doi.org/10.1016/j.radonc.2007.07.009.
Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289-1298. https://doi.org/10.1016/j.ijrobp.2007.02.049.
Nisi KW, Foote RL, Bonner JA, McCaffrey TV. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys. 1998;41(2):371-377. https://doi.org/10.1016/s0360-3016(98)00059-5.
Funk RK, Moore EJ, García JJ, et al. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1674-E1679. https://doi.org/10.1002/hed.24298.
Chen AM, Felix C, Wang P-C, et al. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol. 2017;18(6):803-811. https://doi.org/10.1016/S1470-2045(17)30246-2.
Weinstein GS, Quon H, Newman HJ, et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg. 2012;138(7):628-634. https://doi.org/10.1001/archoto.2012.1166.
Sadeghi N, Mascarella MA, Khalife S, et al. Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer. Head Neck. 2020;42(8):2145-2154. https://doi.org/10.1002/hed.26147.
Machtay M, Perch S, Markiewicz D, et al. Combined surgery and postoperative radiotherapy for carcinoma of the base of radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognostic value of margin status. Head Neck. 1997;19(6):494-499. https://doi.org/10.1002/(sici)1097-0347(199709)19:6<494::aid-hed6>3.0.co;2-u.
Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller R-P, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncol. 2007;43(4):402-407. https://doi.org/10.1016/j.oraloncology.2006.04.015.
Chen MM, Roman SA, Kraus DH, Sosa JA, Judson BL. Transoral robotic surgery: a population-level analysis. Otolaryngol Head Neck Surg. 2014;150(6):968-975. https://doi.org/10.1177/0194599814525747.
Roselló À, Albuquerque R, Roselló-Llabrés X, Marí-Roig A, Estrugo-Devesa A, López-López J. Transoral robotic surgery vs open surgery in head and neck cancer. A systematic review of the literature. Med Oral Patol Oral Cir Bucal. 2020;25(5):e599-e607. https://doi.org/10.4317/medoral.23632.
Slama K, Slouka D, Slipka J, Fischer S. Short-term postoperative distress associated with open vs. transoral robotic surgery (TORS) in patients with T1-T2 carcinomas of the tongue base and supraglottis. Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov. 2016;160(3):423-428. https://doi.org/10.5507/bp.2016.015.
Parhar HS, Gausden E, Patel J, et al. Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma. Head Neck. 2018;40(11):2416-2423. https://doi.org/10.1002/hed.25362.
Sload R, Silver N, Jawad BA, Gross ND. The role of transoral robotic surgery in the management of HPV negative oropharyngeal squamous cell carcinoma. Curr Oncol Rep. 2016;18(9):53. https://doi.org/10.1007/s11912-016-0541-x.
Viros Porcuna D, Pollan Guisasola C, Viña Soria C, et al. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population. Clin Transl Oncol. 2019;19:1303-1311. https://doi.org/10.1007/s12094-019-02256-y.
Persky MJ, Albergotti WG, Rath TJ, et al. Positive margins by oropharyngeal subsite in transoral robotic surgery for T1/T2 squamous cell carcinoma. Otolaryngol Head Neck Surg. 2018;158(4):660-666. https://doi.org/10.1177/0194599817742852.
Gorphe P, Simon C. A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma. Oral Oncol. 2019;98:69-77. https://doi.org/10.1016/j.oraloncology.2019.09.017.
Kelly JR, Park HS, An Y, et al. Comparison of survival outcomes among human papillomavirus-negative cT1-2 N1-2b patients with oropharyngeal squamous cell cancer treated with upfront surgery vs definitive chemoradiation therapy: an observational study. JAMA Oncol. 2017;3(8):1107-1111. https://doi.org/10.1001/jamaoncol.2016.5769.
Garas G, Arora A. Robotic head and neck surgery: history, technical evolution and the future. J Otorhinolaryngol Relat Spec. 2018;80(3-4):117-124. https://doi.org/10.1159/000489464.
Hans S, Delas B, Gorphe P, Ménard M, Brasnu D. Transoral robotic surgery in head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(1):32-37. https://doi.org/10.1016/j.anorl.2011.06.003.
Weinstein GS, O'Malley BWJ, Desai SC, Quon H. Transoral robotic surgery: Does the ends justify the means? Curr Opin Otolaryngol Head Neck Surg. 2009;17(2):126-131. https://doi.org/10.1097/MOO.0b013e32832924f5.